Volume 10, Issue 2 (2022)
Health Educ Health Promot 2022, 10(2): 221-225 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Nejaddadgar N, Jafarzadeh M, Ziapour A, Rezaei F. Determinants of COVID-19 Vaccine Acceptance in Ardabil: a Web-Based Survey. Health Educ Health Promot 2022; 10 (2) :221-225
URL: http://hehp.modares.ac.ir/article-5-56325-en.html
URL: http://hehp.modares.ac.ir/article-5-56325-en.html
1- Department of Health Promotion and Education, School of Public Health, Ardabil University of Medical Sciences, Ardabil, Iran
2- Department of Infectious Diseases, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran
3- Cardiovascular Research Center, Health Institute, Imam-Ali hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
4- Health Education and Promotion Department, health deputy, Ministry of Health, Iran
2- Department of Infectious Diseases, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran
3- Cardiovascular Research Center, Health Institute, Imam-Ali hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
4- Health Education and Promotion Department, health deputy, Ministry of Health, Iran
Abstract: (1362 Views)
Aims: COVID-19 has harmed people's lives and efforts are being made to speed up vaccinations. The growing problem of vaccine uncertainty may affect the uptake of the COVID-19 vaccine. The objectives of this study were to examine the determinants of COVID-19 vaccine acceptance.
Materials & Methods: From July 3 to September 25, 2021, we conducted a web-based, cross-sectional study among the citizens of Ardabil with a snowball sampling strategy under a highly restricted environment. A questionnaire was designed and filled out by 768 participants through social media and email. Associations between COVID-19 vaccine acceptance and determinants were explored using the chi-squared test. Key determinants that predict vaccine acceptance among respondents were modeled through logistic regression analysis.
Findings: Of the 932 survey invitees, 768 responded to the questionnaire (response rate, 82.4%). The majority (55.2%) of the study participants were female. Of the 768 respondents, 486 (63.2%) showed interest to accept the COVID-19 vaccine. Willingness to get the vaccine is relatively high among older age groups (59.4% among 40+ year old), being married (56.9%), and city dwellers participants (83.09%). In multivariate model, respondents who were above 40 years (OR: 0.7; 95% CI:0.5-0.94), and married (OR: 1.43; 95% CI: 0.97-2.09) were significantly associated with vaccine acceptance (p<0.05). Besides, people having trust in the health system and vaccine were most likely to accept the vaccine (OR: 1.26; 95% CI: 1.01-1.56), and those having a higher perceived risk of acquiring infection were 4.83 times (OR: 4.83; 95% CI: 3.78-6.17) higher odds of accepting the vaccine.
Conclusion: Our study identified religious/personal beliefs and risk perceptions as the most important predictors that would be affecting COVID-19 vaccine uptake.
Materials & Methods: From July 3 to September 25, 2021, we conducted a web-based, cross-sectional study among the citizens of Ardabil with a snowball sampling strategy under a highly restricted environment. A questionnaire was designed and filled out by 768 participants through social media and email. Associations between COVID-19 vaccine acceptance and determinants were explored using the chi-squared test. Key determinants that predict vaccine acceptance among respondents were modeled through logistic regression analysis.
Findings: Of the 932 survey invitees, 768 responded to the questionnaire (response rate, 82.4%). The majority (55.2%) of the study participants were female. Of the 768 respondents, 486 (63.2%) showed interest to accept the COVID-19 vaccine. Willingness to get the vaccine is relatively high among older age groups (59.4% among 40+ year old), being married (56.9%), and city dwellers participants (83.09%). In multivariate model, respondents who were above 40 years (OR: 0.7; 95% CI:0.5-0.94), and married (OR: 1.43; 95% CI: 0.97-2.09) were significantly associated with vaccine acceptance (p<0.05). Besides, people having trust in the health system and vaccine were most likely to accept the vaccine (OR: 1.26; 95% CI: 1.01-1.56), and those having a higher perceived risk of acquiring infection were 4.83 times (OR: 4.83; 95% CI: 3.78-6.17) higher odds of accepting the vaccine.
Conclusion: Our study identified religious/personal beliefs and risk perceptions as the most important predictors that would be affecting COVID-19 vaccine uptake.
Article Type: Original Research |
Subject:
Health Education and Health Behavior
Received: 2021/10/13 | Accepted: 2022/01/10 | Published: 2022/03/11
Received: 2021/10/13 | Accepted: 2022/01/10 | Published: 2022/03/11
References
1. World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 72. Geneva: World Health Organization; 2020. [Link]
2. NeJhaddadgar N, Ziapour A, Zakkipour G, Abbas J, Abolfathi M, Shabani M. Effectiveness of telephone-based screening and triage during COVID-19 outbreak in the promoted primary healthcare system: a case study in Ardabil province, Iran. J Public Health. 2020;(30):1301-6. [Link] [DOI:10.1007/s10389-020-01407-8]
3. McKee M, Stuckler D. If the world fails to protect the economy, COVID-19 will damage health not just now but also in the future. Nat Med. 2020;26:640-2. [Link] [DOI:10.1038/s41591-020-0863-y]
4. Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD. How will country-based mitigation measures influence the course of the COVID-19 epidemic?. Lancet . 2020;395(10228):931-4. [Link] [DOI:10.1016/S0140-6736(20)30567-5]
5. Barry M, Ghonem L, Alsharidi A, Alanazi A, Alotaibi NH, Al-Shahrani FS, et al. Coronavirus disease-2019 pandemic in the kingdom of Saudi Arabia: Mitigation measures and hospital preparedness. J Nat Sci Med. 2020;3(3):155-8. [Link] [DOI:10.4103/JNSM.JNSM_29_20]
6. Salmon DA, Dudley MZ, Glanz JM, Omer SB. Vaccine hesitancy: causes, consequences, and a call to action. Am J Prev Med. 2015;49(6 Suppl 4):S391-8. [Link] [DOI:10.1016/j.amepre.2015.06.009]
7. Taherinia M, Hassanvand A. Economic consequences of COVID-19 disease on the Iranian economy; with an emphasis on employment. Q J Nurs Manag. 2020;9(3):43-58. [Persian] [Link]
8. Kaadan MI, Abdulkarim J, Chaar M, Zayegh O, Keblawi MA. Determinants of COVID-19 vaccine acceptance in the Arab world: a cross-sectional study. Global Health Research and Policy. 2021;6(1):1-7. [Link] [DOI:10.1186/s41256-021-00202-6]
9. Thanh Le T, Andreadakis Z, Kumar A, Gomez Roman R, Tollefsen S, Saville M, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19(5):305-6. [Link] [DOI:10.1038/d41573-020-00073-5]
10. NeJhaddadgar N, Toghroli R, Yoosefi lebni J, Melca I, Ziapour A. Exploring the barriers in maintaining the health guidelines amid the covid-19 pandemic: a qualitative study approach. INQ. 2022; 59; 1-11. [Link] [DOI:10.1177/00469580221100348]
11. Larson HJ, de Figueiredo A, Xiahong Z, Schulz WS, Verger P, Johnston IG, et al. The state of vaccine confidence 2016: global insights through a 67-country survey. EBioMedicine. 2016;12:295-301. [Link] [DOI:10.1016/j.ebiom.2016.08.042]
12. Jorgensen P, Mereckiene J, Cotter S, Johansen K, Tsolova S, Brown C. How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015. Vaccine. 2018;36(4):442-52. [Link] [DOI:10.1016/j.vaccine.2017.12.019]
13. Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines (Basel). 2021;9(2):160. [Link] [DOI:10.3390/vaccines9020160]
14. Cornally N, Ann Deasy E, McCarthey G, McAuley C, Moran J, Weathers E, et al. Student nurses' intention to get the influenza vaccine. Br J Nurs. 2013;22(21):1207-11. [Link] [DOI:10.12968/bjon.2013.22.21.1207]
15. Kim SY, Seo JW, Ryu E. Korean college students' attitudes and health behaviour regarding human papillomavirus vaccination. Collegian. 2021;28(1):57-62. [Link] [DOI:10.1016/j.colegn.2020.04.009]
16. Weinstein ND, Kwitel A, McCaul KD, Magnan RE, Gerrard M, Gibbons FX. Risk perceptions: assessment and relationship to influenza vaccination. Health Psychol. 2007;26(2):146-51. [Link] [DOI:10.1037/0278-6133.26.2.146]
17. Williams GC, Minicucci DS, Kouides RW, Levesque CS, Chirkov VI, Ryan RM, et al. Self-determination, smoking, diet and health. Health Educ Res. 2002;17(5):512-21. [Link] [DOI:10.1093/her/17.5.512]
18. Griffith J, Marani H, Monkman H. COVID-19 vaccine hesitancy in Canada: content analysis of tweets using the theoretical domains framework. J Med Internet Res. 2021;23(4):e26874. [Link] [DOI:10.2196/26874]
19. Fisher KA, Bloomstone SJ, Walder J, Crawford S, Fouayzi H, Mazor KM. Attitudes toward a potential SARS-CoV-2 vaccine: a survey of US adults. Ann Intern Med. 2020;173(12):964-73. [Link] [DOI:10.7326/M20-3569]
20. Al-Mohaithef M, Padhi BK. Determinants of Covid-19 vaccine acceptance in Saudi Arabia: a web-based national survey. J Multidiscip Healthc. 2020;13:1657-63. [Link] [DOI:10.2147/JMDH.S276771]
21. Pogue K, Jensen JL, Stancil CK, Ferguson DG, Hughes SJ, Mello EJ, et al. Influences on attitudes regarding potential Covid-19 vaccination in the United States. Vaccines. 2020;8(4):582. [Link] [DOI:10.3390/vaccines8040582]
22. Sethi S, Kumar A, Shaikh M, Hall CA, Kirk JM, Moss P, et al. The UPTAKE study: a cross-sectional survey examining the insights and beliefs of the UK population on COVID-19 vaccine uptake and hesitancy. BMJ Open. 2021;11(6):e048856. [Link]
23. National Academies of Sciences, Engineering and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, Board on Health Sciences Policy, Committee on Equitable Allocation of Vaccine for the Novel Coronavirus, et al. Framework for equitable allocation of COVID-19 vaccine. National Academies Press (US); 2020. [Link]
24. Garcia L. Willingness to pay for a Covid-19 vaccine high in chile. PharmacoEcon Outcomes News. 2020;858(1):35. [Link] [DOI:10.1007/s40274-020-7008-x]
25. Daly M, Robinson E. Willingness to vaccinate against Covid-19 in the US: Longitudinal evidence from a nationally representative sample of adults from April-October 2020. medRxiv. 2020 Nov. [Link] [DOI:10.1101/2020.11.27.20239970]
26. Machida M, Nakamura I, Kojima T, Saito R, Nakaya T, Hanibuchi T, et al. Acceptance of a COVID-19 Vaccine in Japan during the COVID-19 Pandemic. Vaccines. 2021;9(3):210. [Link] [DOI:10.3390/vaccines9030210]
27. Barry M, Al Amri M, Memish ZA. COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia. J Epidemiol Glob Health. 2020;10(1):1-3. [Link] [DOI:10.2991/jegh.k.200218.003]
28. Hassanat AB, Mnasri S, Aseeri M, Alhazmi K, Cheikhrouhou O, Altarawneh G, et al. A simulation model for forecasting covid-19 pandemic spread: Analytical results based on the current saudi Covid-19 data. Sustainability. 202;13(9):4888. [Link] [DOI:10.3390/su13094888]
29. Callaway E. The race for coronavirus vaccines: a graphical guide. Nature. 2020;580:576-7. [Link] [DOI:10.1038/d41586-020-01221-y]
30. Lurie N, Saville M, Hatchett R, Halton J. Developing Covid-19 vaccines at pandemic speed. N Engl J Med. 2020;382(21):1969-73. [Link] [DOI:10.1056/NEJMp2005630]
31. Renner B, Reuter T. Predicting vaccination using numerical and affective risk perceptions: the case of A/H1N1 influenza. Vaccine. 2012;30(49):7019-26. [Link] [DOI:10.1016/j.vaccine.2012.09.064]
32. Yamey G, Schäferhoff M, Hatchett R, Pate M, Zhao F, McDade KK. Ensuring global access to COVID-19 vaccines. Lancet. 2020;395(10234):1405-6. [Link] [DOI:10.1016/S0140-6736(20)30763-7]
33. Nguyen T, Holdt Henningsen K, Brehaut JC, Hoe E, Wilson K. Acceptance of a pandemic influenza vaccine: a systematic review of surveys of the general public. Infect Drug Resist. 2011;4:197-207 [Link] [DOI:10.2147/IDR.S23174]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |